Moderna (MRNA) Reports Q2 Revenues Below Consensus

August 7, 2019 7:27 AM

Moderna (NASDAQ: MRNA) reported Q2 revenue for the quarter came in at $13.08 million versus the consensus estimate of $18.8 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found